Brainstorm is a New York-based biotechnology company that researches and develops stem cell therapies for the treatment of neurodegenerative diseases.
$500K
Jun 08, 2020
-
Bloom is a provider of microbiome, epilepsy and clinical research therapy solutions to individuals.
$500K
Mar 16, 2020
-
Neuropore is a California-based biopharmaceutical company that develops novel therapeutics for the treatment of neurodegenerative disorders.
$500K
Feb 16, 2020
-
ALS ONE focuses on developing treatments for amyotrophic lateral sclerosis disease.
$4M
Nov 30, 2016
-
Amylyx is a Massachusetts-based pharmaceutical company that develops and commercializes novel therapeutics for the treatment of neurodegenerative diseases.
$3M
Jul 19, 2016
-
Frequently Asked Questions about The ALS Association
What is The ALS Association investing in?
The ALS Association has invested in 5 companies including BrainStorm, Bloom Science, Inc. and Neuropore Therapies
What company did The ALS Association invest in?
The ALS Association invested in a total 5 companies including BrainStorm, Bloom Science, Inc. and Neuropore Therapies
What are the top 5 investments by The ALS Association?
The top companies in which The ALS Association invested are BrainStorm, Bloom Science, Inc., Neuropore Therapies, ALS ONE and Amylyx
